KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Net Income (2016 - 2025)

Globus Medical's Net Income history spans 15 years, with the latest figure at $140.6 million for Q4 2025.

  • For Q4 2025, Net Income rose 430.44% year-over-year to $140.6 million; the TTM value through Dec 2025 reached $537.9 million, up 422.53%, while the annual FY2025 figure was $537.9 million, 422.28% up from the prior year.
  • Net Income reached $140.6 million in Q4 2025 per GMED's latest filing, up from $119.0 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $202.8 million in Q2 2025 to a low of -$7.2 million in Q1 2024.
  • Average Net Income over 5 years is $55.6 million, with a median of $47.3 million recorded in 2021.
  • The largest YoY upside for Net Income was 5093.99% in 2024 against a maximum downside of 114.57% in 2024.
  • A 5-year view of Net Income shows it stood at $19.5 million in 2021, then surged by 178.24% to $54.3 million in 2022, then crashed by 72.32% to $15.0 million in 2023, then surged by 76.3% to $26.5 million in 2024, then surged by 430.44% to $140.6 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Net Income are $140.6 million (Q4 2025), $119.0 million (Q3 2025), and $202.8 million (Q2 2025).